Key takeaways from the FDA approval of Wegovy GLP-1 weight loss pill medications
The U.S. Food and Drug Administration (FDA) recently approved Wegovy pills, marking a major milestone in obesity care by authorizing the first oral form of a GLP-1 weight loss medication for chronic weight management. This decision expands treatment choices beyond once-weekly injections and offers millions of adults living with obesity or being overweight a convenient, once-daily tablet option. Approval of the pill version of Wegovy signals a transformational shift in how clinicians and patients can approach weight management and metabolic health. 1. What can I expect from this new oral GLP-1 weight loss medication? Until now, semaglutide-based therapies like Wegovy … Continue reading